EILEEN QUILLIN: Open Payments
NPI 1124587928 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 61 payments from 16 companies in 2025. Trend: 2023 $51 · 2024 $799 · 2025 $1,188
Food & beverage: $1,157Education: $31
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $247 |
| ABBVIE INC. | 15 | $238 |
| Janssen Biotech, Inc. | 6 | $138 |
| Lilly USA, LLC | 4 | $91 |
| PFIZER INC. | 4 | $77 |
| Celltrion USA Inc. | 4 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| GENZYME CORPORATION | 2 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $40 |
Products named: ENTYVIO, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, OMVOH, EOHILIA, VELSIPITY.
Industry payments across CO — which companies pay providers there.
